Cuu Long Pharmaceutical JSC (HOSE:DCL)

Market Cap	2.41T
Revenue (ttm)	1.41T
Net Income (ttm)	43.13B
Shares Out	73.04M
EPS (ttm)	590.12
PE Ratio	55.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	666,338
Average Volume	1,138,075
Open	31,500
Previous Close	31,000
Day's Range	30,250 - 31,500
52-Week Range	19,000 - 32,000
Beta	0.75
RSI	72.88
Earnings Date	Oct 30, 2025

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, nervous system, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, phar...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 885
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DCL

Financial Performance

In 2024, HOSE:DCL's revenue was 1.31 trillion, an increase of 14.24% compared to the previous year's 1.14 trillion. Earnings were 53.57 billion, a decrease of -10.29%.